NEW YORK (GenomeWeb) – Becton Dickinson today entered into a $1.5 billion credit agreement with Citibank, according to forms filed with the US Securities and Exchange Commission.

The agreement is a senior unsecured revolving credit facility that provides BD with $1.5 billion of financing, including a $100 million letter of credit subfacility, and expires in January 2021, according to the SEC documents. BD may access up to an additional $500 million of financing through the facility, for a maximum aggregate commitment of up to $2 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.